Novo Nordisk agreed to cap insulin prices to settle a lawsuit in which Minnesota's attorney general accused the three largest ...

Blockbuster weight loss medications from Novo Nordisk (NVO) and Eli Lilly (NYSE ... Evaluate Pharma projects. The New Jersey-based firm’s plans to seek a regulatory nod for an injectable version ...

The results were consistent with the preliminary results Eli Lilly shared in January, which disappointed investors.